The cutaneous porphyrias: A review

British Journal of Dermatology

Volumn 140, Issue 4, 1999, Pages 573-581

  Murphy, Gillian M ^a  

^a Photobiology Unit   (Ireland)

Author keywords

Congenital erythropoietic porphyria; Cutaneous porphyria; Erythropoietic protoporphyria; Porphyria cutanea tarda; Review

Indexed keywords

DISEASE CLASSIFICATION; GENETIC COUNSELING; GENETIC DISORDER; HUMAN; PHOTODERMATOSIS; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; REVIEW; SKIN PROTECTION;

HUMANS; PORPHYRIA CUTANEA TARDA; PORPHYRIA, ERYTHROPOIETIC; PORPHYRIA, HEPATOERYTHROPOIETIC; PORPHYRIAS;

EID: 0032935239     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02754.x     Document Type: Review

References (76)

1. 1 Casson SE, Elder G, Thomas MA. A plasma porphyrin external quality assurance scheme. In: Proceedings of the ACB National Meeting 1998 108 (Abstr.).
2. 2 Gibbs NK, Traynor N, Ferguson J. Biochemical diagnosis of the cutaneous porphyrias: five years experience of plasma spectrofluorimetry. Br J Dermatol 1995; 133: 18 (Abstr.).
3. 3 Poh-Fitzpatrick MB. A plasma porphyrin fluorescence marker for variegate porphyria. Arch Dermatol 1980; 116: 543-7.
4. 4 Lim H, Cooper D, Sassa S et al. Photo-sensitivity abnormal porphyrin profile and sideroblastic anaemia. J Am Acad Dermatol 1992; 27: 287-92.
5. 5 Sandberg S. Romslo I. Porphyrin-induced photodamage at the cellular and the subcellular level as related to the solubility of the porphyrin. Clin Chim Acta 1981; 109: 1930-201.
6. 6 Doss M, Tiepermann RV, Schneider J et al. New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestations. Klin Wochenschr 1970; 57: 1123-7.
7. 7 Lim HW. Murphy GM. The porphyrias. Clin Dermatol 1996; 14: 1-13.
8. 8 Murphy GM. The cutaneous porphyrias. A review of diagnosis and management. J Acad Dermatovenereol 1993; 2: 11-7.
9. 9 Boffa MJ. Reed P, Weinkove C, Ead RD. Hypertrichosis as the presenting feature of porphyria cutanea tarda. Clin Exp Dermatol 1995; 20: 62-4.
10. 10 Castanet J. Lacour JP, Perrin C et al. Sclerodermatous changes revealing porphyria cutanea tarda. Acta Derm Venereol (Stockh) 1994; 74: 310-1.
11. 11 Adams PC, Powell LW. Porphyria cutanea tarda and HLA-linked haemochromatosis - all in the family? Gastroenterology 1987; 92: 2033-5.
12. 12 Murphy A, Dooly S, Hillary IB, Murphy GM. HCV infection in porphyria cutanea tarda. Lancet 1993; 341: 1534-5.
13. 13 Lacour JP, Bodokh I, Castanet J et al. Porphyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol 1993; 128: 121-3.
14. 14 Burnett JW, Lamon JM, Levin J. Haemophilia, hepatitis and porphyria. Br J Dermatol 1977; 97: 453-5.
15. 15 Connor WJ, Murphy GM, Darby C et al. Porphyrin abnormalities in acquired immune deficiency syndrome. Arch Dermatol 1996; 132: 1443-7.
16. 16 Reilly FM, O'Loughlin S, Murphy GM. Discoid lupus erythematosus and porphyria cutanea tarda. J R Soc Med 1996; 89: 523-4.
17. 17 Guyotat D, Nicolas JF, Augey F et al. Porphyria cutanea tarda after bone marrow transplantation for chronic myelogenous leukemia. Am J Hematol 1990; 34: 69-70.
18. 18 McKenna D, O'Donnell R, Murphy GM. Porphyria cutanea tarda and a report of 4 cases. Photodermatol Photoimmunol Photomed 1997; 13: 143-6.
19. 19 Siersma PD, Rademakers LH, Cleton MI et al. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron. J Hepatol 1995; 23: 259-67.
20. 20 Roberts AG, Whatley SD, Nicklin S et al. The frequency of hemochromatosis-associated alleles is increased in British patients with sporadic porphyria cutanea tarda. Hepatology 1997; 25: 159-61.
21. 21 O'Reilly FM, Darby C, Fogarty J et al. Screening of patients with iron overload to identify haemochromatosis and porphyria cutanea tarda. Arch Dermatol 1997; 133: 1098-101.
22. 22 Robertson AG, Elder GH, Newcombe RG et al. Heterogeneity of familial porphyria cutanea tarda. J Med Genet 1988; 25: 669-76.
23. 23 Roberts AG, Elder GH, De Salamanca et al. A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients. J Invest Dermatol 1995; 104: 500-2.
24. 24 Ramsay CA, Magnus IA, Turnbull A et al. The treatment of porphyria cutanea tarda by venesection. Q J Med 1974; 43: 1-24.
25. 25 Ashton RE, Hawk JLM, Magnus IA. Low dose chloroquine in the treatment of porphyria cutanea tarda. Br J Dermatol 1981; 111: 609-13.
26. 26 Sarkell B, Patterson JW. Treatment of porphyria cutanea tarda of end stage renal failure with erythropoietin. J Am Acad Dermatol 1993; 29: 499-500.
27. 27 Okano J, Horie Y, Kawasaki H, Kondo M. Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C. Hepatogastroenterology 1997; 44: 525-8.
28. 28 De Leo VA, Poh-Fitzpatrick MB, Matthews-Roth MM et al. Erythropoietic protoporphyria: ten years of experience. Am J Med 1976; 60: 8-22.
29. 29 Norris PG, Baker CS, Roberts JE, Hawk JL. Treatment of erythropoietic protoporphyria with N-acetylcysteine. Arch Dermatol 1995; 131: 354-5.
30. 30 Matthews-Roth MM, Kosner B, Renfell K, Roberts JK. A double-blind study of cysteine photoprotection in erythropoietic protoporphyria. Photodermatol Photoimmunol Photomed 1994; 10: 244-8.
31. 31 Farr PM, Diffey BL, Matthew N. Inhibition of photosensitivity in erythropoietic protoporphyria with terfenadine. Br J Dermatol 1990; 122: 809-15.
32. 32 Collins P, Ferguson J. Narrow band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses. Br J Dermatol 1995; 132: 956-63.
33. 33 McCullough AJ. Barron D, Mullen KD et al. Fecal protoporphyrin excretion in erythropoietic protoporphyria: effect of cholestyramine and bile acid feeding. Gastroenterology 1988; 94: 177-81.
34. 34 Mion FB, Faure JL, Berger F et al. Liver transplantation for erythropoietic protoporphyria. Report of a new case with subsequent medium-term follow-up. J Hepatol 1992; 16: 203-7.
35. 35 Tishler PV, Winston SH. Rapid improvement in the chemical pathology of congenital erythropoietic protoporphyria with treatment with super activated charcoal. Methods Findings Exp Clin Pharmacol 1990; 12: 645-8.
36. 36 Murphy A, Gibson G, Elder GH et al. Adult-onset congenital erythropoietic porphyria (Gunther's disease) presenting with thrombocytopenia. J R Soc Med 1995; 88: 357-8.
37. 37 Kauffman L, Evans DIK, Stevens RF, Weinkove C. Bone marrow transplantation for congenital erythropoietic porphyria. Lancet 1991; 337: 1510-11.
38. 38 Mustajoki P, Nordmann Y. Early administration of heme arginate for acute porphyric attacks. Arch Int Med 1993; 153: 2004-8.
39. 39 Herrick AL, McColl KE, Wallace AM et al. A LHRH analogue treatment for the prevention of premenstrual attacks of acute porphyria. Q J Med 1990; 75: 355-63.
40. 40 Dover SB, Moore MR, Fitzsimmons EJ et al. Tin protoporphyrin prolongs the biochemical remission produced by heme arginate in acute hepatic porphyria. Gastroenterology 1993; 105: 590-4.
41. 41 Murphy GM, Hawk JLM, Corbett MF, Magnus IA. The UK erythropoietic protoporphyria register. Br J Dermatol 1985; 113 (Suppl. 29): 11.
42. 42 Carithers RL. Follow up after liver transplantation for protoporphyric liver disease. Liver Transplantation Surg 1996; 2: 269-75.
43. 43 Bonkowsky HL, Schned AR. Fatal liver failure in protoporphyria. Synergism between ethanol excess and the genetic defect. Gastroenterology 1986; 90: 191-201.
44. 44 Rademakers LH, Koningsberger JC, Sorber CW et al. Accumulation of iron in erythroblasts of patients with erythropoietic protoporphyria. Eur J Clin Invest 1993; 23: 130-8.
45. 45 Meerman L, Verwer R, Slooff MJ et al. Perioperative measures during liver transplantation for erythropoietic protoporphyria. Transplantation 1994; 57: 155-8.
46. 46 Herbert A, Corbin D, Williams A et al. Erythropoietic protoporphyria: unusual skin and neurological problems after liver transplantation. Gastroenterology 1991; 100: 1753-7.
47. 47 Murphy GM, Hawk JLM, Nicholson DC et al. Congenital erythropoietic porphyria (Gunther's disease). Clin Exp Dermatol 1987; 12: 61-5.
48. 48 MacDonald A, Nicholson D, Williams R. Late onset erythropoietic uroporphyria. Br J Dermatol 1976; 95 (Suppl. 14): 30-3.
49. 49 Thomas C, Ged C, Nordmann Y et al. Correction of congenital erythropoietic porphyria by bone marrow transplantation. J Pediatr 1996; 129: 453-6.
50. 50 Zix-Kieffer I, Langer B, Eyer D et al. Successful cord blood stem cell transplantation for congenital erythropoietic porphyria (Gunther's disease). Bone Marrow Transplant 1996; 18: 217-20.
51. 51 Ged C, Moreau-Gaudry F, Taine L et al. Prenatal diagnosis in congenital erythropoietic porphyria by metabolic measurement and DNA mutation analysis. Prenatal Diagnosis 1996; 16: 83-6.
52. 52 Mustajoki P, Timonen K, Gorchein A et al. Sustained high plasma 5-aminolaevulinic acid concentration in a volunteer: no porphyric symptoms. Eur J Clin Invest 1992; 22: 407-11.
53. 53 Medenica R, Lazovic G, Huschart T et al. Polypeptide levels increase during acute onset of hepatic porphyrias. Cell Mol Biol 1997; 43: 9-27.
54. 54 Anonymous. Acute porphyrias. In: British National Formulary London: British Medical Association and Royal Pharmaceutical Society of Great Britain. 1998.
55. 55 Long C, Smyth SJ, Woolf J et al. Detection of latent variegate porphyria by fluorescence emission spectroscopy of plasma. Br J Dermatol 1993; 129: 9-13.
56. 56 Meissner PN, Dailey TA, Hift RJ et al. A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria. Nat Genet 1996; 13: 95-7.
57. 57 Pretorius C, du Toit JJ, du Preez JC, Meissner PN. Diagnosis of variegate porphyria at birth by demonstration of the R59W mutation. S Afr Med J 1997; 87: 763-765.
58. 58 Kordac V, Martesed P, Zeman J et al. Increased erythrocyte protoporphyrin in homozygous variegate porphyria. Photodermatology 1985; 2: 2576-9.
59. 59 Murphy GM, Hawk JLM, Magnus IA et al. Homozygous variegate porphyria: two similar cases in unrelated families. J R Soc Med 1986; 79: 361-3.
60. 60 Grandchamp B, Phung N, Nordmann Y. Homozygous case of hereditary coproporphyria. Lancet 1977; ii: 1348-9.
61. 61 Cotter PD, Drabkin HA, Varkay T et al. Assignment of the human housekeeping d-aminolevulinate synthase gene (ALAS1) to chromosome band 3p21.1 by PCR analysis of somatic cell hybrids. Cytogenet Cell Genet 1995; 69: 207-8.
62. 62 Boyer G, Nonneman D, Shibuya H et al. A PCR RFLP marker for the erythroid aminolaevulinate synthase gene ALAS2 on canine chromosome X. Anim Genet 1995; 26: 206-7.
63. 63 Kaya AH, Plewinska M, Wong DM et al. Human aminolaevulinate dehydratase (ALAD) gene: structure and alternative splicing of the erythroid and housekeeping mRNAs. Genomics 1994; 19: 242-8.
64. 64 Namba H, Narahara K, Yokoyama Y et al. Assignment of human porphobilinogen deaminase to 11q24.1-q24.2 by in situ hybridisation und gene dosage studies. Cytogenet Cell Genet 1991; 57: 105-8.
65. 65 Schreiber WE, Fong F, Nasser BA et al. Heteroduplex analysis detects frameshift and point mutations in patients with acute intermittent porphyria. Jpn J Hum Genet 1995; 40: 207-13.
66. 66 Astrin KH, Warner CA, Yoo HW et al. Regional assignment of the human uroporphyrinogen III synthase (URO-S) gene to chromosome 10q25.2-q26.3. Hum Genet 1991; 87: 18-22.
67. 67 McLellan T, Pryor MA, Kushner JP et al. Assignment of uroporphyrinogen decarboxylase (UROD) to the pter-p21 region of human chromosome 1. Cytogenet Cell Genet 1985; 39: 224-7.
68. 68 Cacheux V, Martasek P, Fougerousse F et al. Localisation of the human coproporphyrinogen oxidase gene to chromosome band 3q12. Hum Genet 1994; 94: 557-9.
69. 69 Nishimura K, Taketani S, Inokuchi H. Cloning of a human c DNA for protoporphyrinogen oxidase by complementation in vivo of a heme G mutant of Escherichia coli. Hum Mol Genet 1994; 3: 477-80.
70. 70 Roberts GA, Whatley SD, Daniels J et al. Partial characterisation and assignment of the gene for protoporphyrinogen oxidase and variegate porphyria to human chromosome 1q23. Hum Mol Genet 1995; 4: 2387-90.
71. 71 Whitcombe DM, Carter NP, Albertson DG et al. Assignment of the human ferrochelatase gene (FECH) and a locus for protoporphyria to chromosome 18q22. Genomics 1991; 11: 1152-4.
72. 72 Gouya L, Deybach JC, Lamoril J et al. Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele. Am J Hum Genet 1996; 58: 292-9.
73. 73 Went LN, Klasen EC. Genetic aspects of erythropoietic protoporphyria. Ann Hum Genet 1984; 48: 105-17.
74. 74 Nunn AVW, Norris P, Hawk JLM, Cox TM. Zinc chelatase in human lymphocytes: detection of the enzymatic defect in erythropoietic protoporphyria. Anal Biochem 1988; 174: 146-50.
75. 75 Sarkany RPE, Alexander GJMA, Cox TM. Recessive inheritance of erythropoietic protoporphyria with liver failure. Lancet 1994; 343: 1394-6.
76. 76 Xu W, Warner CA, Desnick RJ. Congenital erythropoietic porphyria: identification and expression of 10 mutations in the uroporphyrinogen III synthase gene. J Clin Invest 1995; 95: 905-12.